Mario Gabelli Seagen Inc. Transaction History

Gamco Investors, Inc. Et Al

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $160,868 - $181,574	-840 Reduced 4.33%	18,560 $3.94 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $1.14 Million - $1.25 Million	6,050 Added 45.32%	19,400 $3.73 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $1.7 Million - $2.71 Million	13,350 New	13,350 $2.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.